Kura Oncology, Inc.
KURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $775,658 | $505,371 | $576,939 | $758,955 |
| - Cash | $95,287 | $81,948 | $51,269 | $224,462 |
| + Debt | $14,130 | $12,964 | $19,354 | $16,594 |
| Enterprise Value | $694,501 | $436,387 | $545,024 | $551,087 |
| Revenue | $20,750 | $15,288 | $14,108 | $53,883 |
| % Growth | 35.7% | 8.4% | -73.8% | – |
| Gross Profit | $17,538 | $15,288 | $14,108 | $53,883 |
| % Margin | 84.5% | 100% | 100% | 100% |
| EBITDA | -$73,952 | -$65,507 | -$64,700 | -$16,592 |
| % Margin | -356.4% | -428.5% | -458.6% | -30.8% |
| Net Income | -$74,116 | -$66,122 | -$57,429 | -$19,217 |
| % Margin | -357.2% | -432.5% | -407.1% | -35.7% |
| EPS Diluted | -0.85 | -0.75 | -0.66 | -0.22 |
| % Growth | -13.3% | -13.6% | -200% | – |
| Operating Cash Flow | -$80,627 | -$28,777 | -$71,927 | $269,131 |
| Capital Expenditures | -$2,567 | -$1,458 | -$292 | -$372 |
| Free Cash Flow | -$83,194 | -$30,235 | -$72,219 | $268,759 |